​
​

Biohaven Pharmaceutical Company Ownership | Who Owns Biohaven Pharmaceutical Company?

OverviewForecastFinancialsChart

Biohaven Pharmaceutical Company Ownership Summary

Biohaven Pharmaceutical Company is owned by 101.33% institutional investors, 11.47% insiders. Vanguard group is the largest institutional shareholder, holding 8.91% of BHVN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.49% of its assets in Biohaven Pharmaceutical Company shares.

BHVN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockBiohaven Pharmaceutical Company101.33%11.47%-12.80%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.52M2.49%87.00K
BB Biotech AG Ord2.04M2.15%-
Vanguard Small Cap Index2.00M1.98%109.68K
T. Rowe Price Health Sciences1.85M1.95%12.38K
iShares Russell 2000 ETF1.94M1.92%-4.35K
Fidelity Select Biotechnology1.79M1.77%-26.70K
SPDR® S&P Biotech ETF1.52M1.50%16.80K
Vanguard Small Cap Value Index Inv1.35M1.34%70.84K
Janus Henderson Global Life Sciences D1.20M1.26%-829.00
Janus Henderson Global Life Sciences1.18M1.17%-4.89K

Recent Insider Transactions

DateNameRoleActivityValue
Oct 02, 2024CHILDS JOHN W-Buy$999.97K
Oct 02, 2024Coric Vlad Chief Executive OfficerBuy$999.97K
Sep 24, 2024Bailey Gregory-Buy$220.97K
Jul 18, 2024CHILDS JOHN W-Buy$1.01M
Jun 17, 2024Car Bruce Chief Scientific OfficerBuy$1.01M

Insider Transactions Trends

DateBuySell
2024 Q42-
2024 Q32-
2024 Q210-
2024 Q1--
2023 Q461

BHVN Ownership FAQ

Who Owns Biohaven Pharmaceutical Company?

Biohaven Pharmaceutical Company shareholders are primarily institutional investors at 101.33%, followed by 11.47% insiders and -12.80% retail investors. The average institutional ownership in Biohaven Pharmaceutical Company's industry, Biotech Stocks , is 45.35%, which Biohaven Pharmaceutical Company exceeds.

Who owns the most shares of Biohaven Pharmaceutical Company?

Biohaven Pharmaceutical Company’s largest shareholders are Vanguard group (7.27M shares, 8.91%), Stifel financial (6.48M shares, 7.94%), and Blackrock (6.17M shares, 7.56%). Together, they hold 24.41% of Biohaven Pharmaceutical Company’s total shares outstanding.

Does Blackrock own Biohaven Pharmaceutical Company?

Yes, BlackRock owns 7.56% of Biohaven Pharmaceutical Company, totaling 6.17M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 214.15M$. In the last quarter, BlackRock increased its holdings by 446.83K shares, a 7.81% change.

Who is Biohaven Pharmaceutical Company’s biggest shareholder by percentage of total assets invested?

Rp management is Biohaven Pharmaceutical Company’s biggest shareholder by percentage of total assets invested, with 57.00% of its assets in 2.94M Biohaven Pharmaceutical Company shares, valued at 101.93M$.

Who is the top mutual fund holder of Biohaven Pharmaceutical Company shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Biohaven Pharmaceutical Company shares, with 2.49% of its total shares outstanding invested in 2.52M Biohaven Pharmaceutical Company shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools